Related Experiment Video
Updated: Dec 3, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Long noncoding RNA MAGI2-AS3 inhibits bladder cancer progression through MAGI2/PTEN/epithelial-mesenchymal transition
Daqing Shen1,2, Jing Xu2, Xiande Cao2
1Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Background:
Long noncoding RNA (lncRNA) are critical regulators of tumor progression.
Objective:
To determine how the lncRNA membrane associated guanylate kinase, WW and PDZ domain-containing 2 (MAG12) antisense RNA 3 (MAGI2-AS3) and the phosphatase and tensin homolog (PTEN) gene function in regulating bladder cancer (Bca) progression.
Methods:
Total RNA from 80 Bca tissues and 30 paired para-cancerous tissues from patients was sequentially extracted, quantified, purified, and reverse transcribed using RT-PCR. A library was constructed and sequenced. Four Bca cell lines and a normal urothelial cell line were transfected with lentiviral plasmids, and cell migration and invasion were assayed in vitro. An orthotopic mouse model of Bca was created for in vivo studies.
Results:
MAGI2-AS3 expression was significantly downregulated in Bca, compared with normal tissues, and negatively associated with tumor stage and a poor prognosis. MAGI2-AS3 and its sense RNA MAGI2 showed significant and positive correlation. The expression of MAGI2 and its downstream gene, PTEN, increased in Bca cells overexpressing MAGI2-AS3, and interference by MAGI2 expression reversed the migration and invasion inhibited by MAGI2-AS3 overexpression.
Conclusion:
MAGI2-AS3 overexpression inhibited Bca cell progression by regulating the MAGI2/PTEN/epithelial-mesenchymal transition, offering novel insights into the mechanism of Bca progression.
Insights
Overexpression of MAGI2-AS3, a long noncoding RNA, inhibits bladder cancer progression by regulating the MAGI2/PTEN pathway. This finding offers new insights into bladder cancer mechanisms.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long noncoding RNAs (lncRNAs) play crucial roles in regulating tumor development.
- Understanding specific lncRNAs involved in bladder cancer (Bca) progression is essential.
Purpose of the Study:
- To investigate the role of the lncRNA MAGI2-AS3 and the PTEN gene in bladder cancer progression.
- To elucidate the functional relationship between MAGI2-AS3 and the MAGI2/PTEN pathway in Bca.
Main Methods:
- Analysis of MAGI2-AS3 expression in 80 Bca tissues and paired adjacent tissues.
- In vitro assays (transfection, cell migration, invasion) in Bca cell lines.
- In vivo orthotopic mouse model for Bca studies.
Main Results:
- MAGI2-AS3 was significantly downregulated in Bca tissues and correlated with poorer prognosis.
- MAGI2-AS3 overexpression increased MAGI2 and PTEN expression in Bca cells.
- MAGI2-AS3 overexpression inhibited Bca cell migration and invasion, partly via the MAGI2/PTEN axis.
Conclusions:
- MAGI2-AS3 overexpression suppresses bladder cancer progression.
- The MAGI2/PTEN pathway is a key mechanism regulated by MAGI2-AS3 in Bca.
- MAGI2-AS3 represents a potential therapeutic target for bladder cancer.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
Non-Canonical Wnt Signaling Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
